Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02872233 · ClinicalTrials.gov registry record · NA
Sun Protection Factor (SPF) / UVA Protection Factor (UVAPF) Assay
A NA study, sponsored by Bayer.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT02872233: Completed NA study, sponsored by Bayer.
NCT02872233 is a NA study that has completed, run by Bayer. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02872233, a NA study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
Evaluation of the effectiveness of a sunscreen product by determining its Sun Protection Factor (SPF) on the skin of human subjects.
Primary Outcome
ISO/COLIPA Sun Protection FactorTest Method.
Interventions
- DRUG BAY 987519
- DRUG SPF 15 Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2015-05-26 |
| Est. Completion | 2015-06-10 |
| Phase | NA |
What the finished NCT02872233 record still lists
NCT02872233 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which BAY 987519 is the first listed.
NCT02872233 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02872233 about?
NCT02872233 is a clinical study titled "Sun Protection Factor (SPF) / UVA Protection Factor (UVAPF) Assay". Evaluation of the effectiveness of a sunscreen product by determining its Sun Protection Factor (SPF) on the skin of human subjects.
What is the current status of trial NCT02872233?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2015-05-26. Estimated completion is 2015-06-10.
What interventions are being tested in trial NCT02872233?
The interventions under investigation include: BAY 987519 (DRUG), SPF 15 Control (DRUG).
Who is sponsoring clinical trial NCT02872233?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02872233's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI